Pharmacotherapy for Disorders of Consciousness: Are ‘Awakening’ Drugs Really a Possibility? Rosella CiurleoPlacido BramantiRocco Salvatore Calabrò Leading Article 30 October 2013 Pages: 1849 - 1862
Therapeutic Options for Visceral Leishmaniasis Begoña Monge-MailloRogelio López-Vélez Review Article Open access 30 October 2013 Pages: 1863 - 1888
Therapeutic Options for Old World Cutaneous Leishmaniasis and New World Cutaneous and Mucocutaneous Leishmaniasis Begoña Monge-MailloRogelio López-Vélez Review Article 30 October 2013 Pages: 1889 - 1920
Gender Differences in Cardiovascular Therapy: Focus on Antithrombotic Therapy and Percutaneous Coronary Intervention Juan Luis Gutiérrez-ChicoJulinda Mehilli Review Article 24 October 2013 Pages: 1921 - 1933
Prucalopride: A Review of Its Use in the Management of Chronic Constipation Gillian M. Keating Adis Drug Evaluation 06 November 2013 Pages: 1935 - 1950
Fosfomycin Trometamol: A Review of Its Use as a Single-Dose Oral Treatment for Patients with Acute Lower Urinary Tract Infections and Pregnant Women with Asymptomatic Bacteriuria Gillian M. Keating Adis Drug Evaluation 08 November 2013 Pages: 1951 - 1966
Riociguat: First Global Approval Daniel ConoleLesley J. Scott R & D Insight Report 12 November 2013 Pages: 1967 - 1975
Efinaconazole: First Global Approval Trina PatelSohita Dhillon R&D Insight Report 19 November 2013 Pages: 1977 - 1983
